Zai Lab Ltd SEC filings ZLAB
Zai Lab Ltd has 739 filings in SEC EDGAR's recent list, going back to May 30, 2017. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Nov 15, 2024 | — |
| 424B5 | Prospectus supplement | Nov 13, 2024 | — |
| S-8 | Employee stock plan registration | Jun 18, 2024 | — |
| S-3ASR | Automatic shelf registration | Apr 19, 2024 | — |
| F-6EF | Filing | Jul 14, 2023 | — |
| S-8 | Employee stock plan registration | Oct 28, 2022 | — |
| S-8 | Employee stock plan registration | May 9, 2022 | — |
| 424B3 | Prospectus | Mar 30, 2022 | — |
| S-8 | Employee stock plan registration | Aug 9, 2021 | — |
| 424B5 | Prospectus supplement | Apr 21, 2021 | — |
| 424B5 | Prospectus supplement | Apr 19, 2021 | — |
| S-3ASR | Automatic shelf registration | Apr 19, 2021 | — |
| 424B5 | Prospectus supplement | Sep 23, 2020 | — |
| 424B5 | Prospectus supplement | Sep 16, 2020 | — |
| S-8 | Employee stock plan registration | Jun 17, 2020 | — |
| 424B2 | Prospectus | Jan 24, 2020 | — |
| 424B5 | Prospectus supplement | Jan 21, 2020 | — |
| 424B2 | Prospectus | May 6, 2019 | — |
| 424B5 | Prospectus supplement | May 1, 2019 | — |
| F-3ASR | Form f-3asr | Mar 29, 2019 | — |
| 424B4 | Prospectus | Sep 7, 2018 | — |
| F-1/A | Filing | Sep 5, 2018 | — |
| F-1/A | Filing | Sep 5, 2018 | — |
| F-1 | Registration statement (foreign issuer) | Aug 31, 2018 | — |
| S-8 | Employee stock plan registration | Nov 16, 2017 | — |
| 424B4 | Prospectus | Sep 21, 2017 | — |
| F-1MEF | Filing | Sep 20, 2017 | — |
| F-1/A | Filing | Sep 20, 2017 | — |
| F-1/A | Filing | Sep 1, 2017 | — |
| F-6 | Filing | Aug 30, 2017 | — |
| F-1/A | Filing | Aug 23, 2017 | — |
| F-1 | Registration statement (foreign issuer) | Aug 15, 2017 | — |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ZLAB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Shanghai
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1704292
- Former names
- Zai Lab Ltd (until Nov 5, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.